Curiox Biosystems Co., Ltd.
445680·KOSDAQ·8 grantsAmendments merged
- Shares granted, cumulative
- 236,550shares
- Next lockup release
- D-170
- 2027-02-06
Against the share price
At the 2026-08-18 close- Shares with a reason to exercise
- 188,950 shares
- 1.10% of shares outstanding
- Sellable right now
- 88,100 shares
- 47% of the shares with a reason to exercise
- Unrealized paper gain (to the employees)
- ₩3.6B
Potential dilution
Shares by strike price
- ₩117,60248K shares
- ₩44,750Latest price
- ₩43,0483K shares
- ₩42,7217K shares
- ₩38,96456K shares
- ₩22,71133K shares
- ₩19,72121K shares
- ₩16,10270K shares
Below the line (strike < Latest price) sits above the strike price: 189K shares, 80% of the shares still inside their exercise window.
Options the share price has risen past gain a reason to be exercised and sold once the lockup ends. Filings do not show what has already been exercised or forfeited, so these figures are on a cumulative grants basis and the shares actually outstanding may be fewer.
Share price vs. strike price
A strike price is fixed on the grant date; only the share price moves. Where the price line crosses a dashed line is when that block of options first had a reason to be exercised.
- Strike ₩16,10270K sharesabove
- Strike ₩38,96456K sharesabove
- Strike ₩117,60248K shares
- Strike ₩22,71133K sharesabove
Recipients by role
- Registered director1 person5%
- Unregistered officer1 person0%
- Employee38 people21%
- Other · unknown96 people74%
Sorted from the relation text written in the filings (136 recipients). Officers of affiliates and subsidiaries are counted as unregistered officers. This company reported many recipients under a lumped label such as “executives and employees”, or left the field blank, so the breakdown is limited.
Shares granted by year
Cumulative grants per recipient
1 named · 134 withheld| Recipient | Shares, cumulative | Average strike | Exercisable | Paper gain |
|---|---|---|---|---|
| 14,0005.2% | ₩17,735 | 1,000 | ₩378.2M | |
| 257,40094.8% | ₩46,564 | 142,700 | ₩3B |
Recipients granted less than 10 in 10,000 of total shares issued have their names withheld under the disclosure rules; they cannot be split apart, so they are grouped into one row. Rows that pack several people onto one line, such as “OOO and 6 others”, are grouped there too, with the headcount read from that text — the split between them is never disclosed, so “my share” can only be prefilled with the per-person average. Filings carry no employee number or year of birth, so people with the same name are added together as one. “Exercisable” counts shares whose lockup has already ended, and any paper gain accrues to the employees holding the options.
Grant history · lockup schedule
Exercisable shares over time
It rises on the day a lockup ends and falls on the day an exercise window closes. Options actually exercised are not subtracted, because only executives have to report them.
20262 grants · 54,700 sharesReleases 2028-03-31
- Granted2026-08-11
- Exercise starts2028-08-11
- Exercise ends2036-08-10
- Shares granted
- 7,100shares
- Strike price
- 42,721KRW
- Grant method
- New share issuance
- Approved by
- Board of directors
Above the strike price₩2,029 per share₩14.4M[Amended] Report on grant of stock options
- Granted2026-03-31
- Exercise starts2028-03-31
- Exercise ends2036-03-30
- Shares granted
- 47,600shares
- Strike price
- 117,602KRW
- Grant method
- New share issuance
- Approved by
- Board of directors
Below the strike priceShare price below the strike — no reason to exerciseReport on grant of stock options
20254 grants · 93,750 sharesReleases 2027-02-06
- Granted2025-09-01
- Exercise starts2027-09-01
- Exercise ends2035-08-31
- Shares granted
- 3,200shares
- Strike price
- 43,048KRW
- Grant method
- New share issuance
- Approved by
- Board of directors
Above the strike price₩1,702 per share₩5.4MReport on grant of stock options
- Granted2025-03-31
- Exercise starts2027-03-31
- Exercise ends2035-03-30
- Shares granted
- 56,800shares
- Strike price
- 16,102KRW
- Grant method
- New share issuance
- Approved by
- Board of directors
Above the strike price₩28,648 per share₩1.6BReport on grant of stock options
- Granted2025-03-31
- Exercise starts2027-03-31
- Exercise ends2035-03-30
- Shares granted
- 13,000shares
- Strike price
- 16,102KRW
- Grant method
- New share issuance
- Approved by
- Shareholders' meeting
Above the strike price₩28,648 per share₩372.4MReport on grant of stock options
- Granted2025-02-06
- Exercise starts2027-02-06
- Exercise ends2035-02-05
- Shares granted
- 20,750shares
- Strike price
- 19,721KRW
- Grant method
- New share issuance
- Approved by
- Board of directors
Above the strike price₩25,029 per share₩519.4MReport on grant of stock options
20242 grants · 88,100 shares
- Granted2024-08-16
- Exercise starts2026-08-16
- Exercise ends2034-08-15
- Shares granted
- 32,500shares
- Strike price
- 22,711KRW
- Grant method
- New share issuance
- Approved by
- Board of directors
Above the strike price₩22,039 per share₩716.3MReport on grant of stock options
- Granted2024-03-28
- Exercise starts2026-03-28
- Exercise ends2034-03-27
- Shares granted
- 55,600shares
- Strike price
- 38,964KRW
- Grant method
- New share issuance
- Approved by
- Shareholders' meeting
Above the strike price₩5,786 per share₩321.7M[Amended] Report on grant of stock options
Options actually exercised
These come from ownership reports filed by executives and major shareholders that give a stock option exercise as the reason. Employees have no such reporting duty, so this is not the company's total exercised volume. Reports filed for the same date at the same strike price are merged into one row, and they are not matched to the individual grants listed above.
- 2024-12-1214,312 sharesStrike ₩4,4162 reports
Every figure here is parsed mechanically from the original DART filing (document.xml). “Exercise starts (estimated)” means the filing did not state an exercise period, so the date is the grant date plus two years under Article 340-2(4) of the Korean Commercial Act and may differ from the actual terms. Always read the original filing before making any decision.